Onto Innovation, OSI Systems, NVE, Nano Dimension, and Biodexa Pharmaceuticals are the five Nanotechnology stocks to watch today, according to MarketBeat's stock screener tool. Nanotechnology stocks are equity shares of companies that research, develop or manufacture products using nanoscale materials and engineering techniques. These firms operate in sectors ranging from electronics and healthcare to energy and materials science, exploiting unique properties at the atomic or molecular level. Investors buy nanotechnology stocks to gain exposure to potential breakthroughs—such as targeted drug delivery, advanced coatings and next-generation semiconductors—while bearing in mind the field’s long development cycles and regulatory uncertainties. These companies had the highest dollar trading volume of any Nanotechnology stocks within the last several days.
Onto Innovation (ONTO)
Onto Innovation Inc. engages in the design, development, manufacture, and support of process control tools that performs optical metrology. The company offers lithography systems and process control analytical software. It also offers process and yield management solutions, and device packaging and test facilities through standalone systems for optical metrology, macro-defect inspection, packaging lithography, and transparent and opaque thin film measurements.
Shares of ONTO stock traded down $1.58 during trading hours on Friday, reaching $98.66. The company's stock had a trading volume of 1,636,334 shares, compared to its average volume of 968,945. The firm's 50 day simple moving average is $103.68 and its 200-day simple moving average is $140.92. The company has a market capitalization of $4.82 billion, a price-to-earnings ratio of 22.32, a PEG ratio of 0.64 and a beta of 1.45. Onto Innovation has a fifty-two week low of $85.88 and a fifty-two week high of $238.93.
Read Our Latest Research Report on ONTO
OSI Systems (OSIS)
OSI Systems, Inc. designs and manufactures electronic systems and components. It operates in three segments: Security, Healthcare, and Optoelectronics and Manufacturing. The Security segment offers baggage and parcel inspection, cargo and vehicle inspection, hold baggage and people screening, radiation monitoring, explosive and narcotics trace detection systems, and optical inspection systems under the Rapiscan name.
Shares of OSIS stock traded down $0.46 during trading hours on Friday, reaching $224.05. The company's stock had a trading volume of 232,737 shares, compared to its average volume of 205,326. The firm's 50 day simple moving average is $220.36 and its 200-day simple moving average is $198.75. The company has a market capitalization of $3.76 billion, a price-to-earnings ratio of 27.26, a PEG ratio of 2.04 and a beta of 1.28. The company has a quick ratio of 1.38, a current ratio of 2.11 and a debt-to-equity ratio of 0.53. OSI Systems has a fifty-two week low of $129.18 and a fifty-two week high of $241.64.
Read Our Latest Research Report on OSIS
NVE (NVEC)
NVE Corporation develops and sells devices that use spintronics, a nanotechnology that relies on electron spin to acquire, store, and transmit information in the United States and internationally. The company manufactures spintronic products, including sensors and couplers for use in acquiring and transmitting data.
NASDAQ:NVEC traded down $0.27 during trading hours on Friday, hitting $74.03. The company's stock had a trading volume of 169,240 shares, compared to its average volume of 29,165. The stock has a fifty day simple moving average of $68.22 and a 200-day simple moving average of $70.10. The company has a market capitalization of $358.31 million, a P/E ratio of 23.80 and a beta of 1.15. NVE has a twelve month low of $51.50 and a twelve month high of $89.98.
Read Our Latest Research Report on NVEC
Nano Dimension (NNDM)
Nano Dimension Ltd., together with its subsidiaries, engages in additive manufacturing solutions in Israel and internationally. The company offers 3D printers, comprising AME systems, which are inkjet printers, that produces Hi-PEDs by depositing proprietary conductive and dielectric substances, as well as integrates in-situ capacitors, antennas, coils, transformers, and electromechanical components; micro additive manufacturing systems, a digital light processing printers (DLP) that achieves production-grade polymer and composite parts; and industrial additive manufacturing systems, that utilizes a patented foil system that fabricates ceramic and metal parts.
Shares of NNDM traded up $0.12 during mid-day trading on Friday, reaching $1.64. The company had a trading volume of 3,700,434 shares, compared to its average volume of 1,670,892. The company's 50 day simple moving average is $1.54 and its 200 day simple moving average is $1.95. Nano Dimension has a 1-year low of $1.34 and a 1-year high of $2.74. The company has a market capitalization of $356.34 million, a price-to-earnings ratio of -4.10 and a beta of 1.13.
Read Our Latest Research Report on NNDM
Biodexa Pharmaceuticals (BDRX)
Biodexa Pharmaceuticals Plc, a clinical stage biopharmaceutical company, focuses on developing a pipeline of products for the treatment of Type 1 diabetes and rare/orphan cancers of the brain. Its lead product candidate Tolimidone, a selective activator of the lyn kinase enzyme, currently under Phase II studies for the treatment of Type 1 diabetes.
Biodexa Pharmaceuticals stock traded down $0.06 during mid-day trading on Friday, reaching $0.87. The company had a trading volume of 268,980 shares, compared to its average volume of 1,100,047. Biodexa Pharmaceuticals has a fifty-two week low of $0.78 and a fifty-two week high of $41.50. The company has a debt-to-equity ratio of 0.01, a quick ratio of 1.75 and a current ratio of 1.75. The business has a fifty day simple moving average of $1.21 and a 200 day simple moving average of $2.57.
Read Our Latest Research Report on BDRX
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Onto Innovation, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Onto Innovation wasn't on the list.
While Onto Innovation currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report